immunosuppressive or disease-modifying antirheumatic drugssystemic lupus erythematosusSLE
…ross-sectional study, women aged 18–45 years with SLE receiving immunosuppressive or disease-modifying antirheumatic drugs were compared with immunocompetent women, selected from the sam…